Year |
Citation |
Score |
2019 |
Nera B, Huang HS, Hendrickson EA, Xu L. Both the Classical and Alternative Non-Homologous End Joining Pathways Contribute to the Fusion of Drastically Shortened Telomeres Induced by TRF2 Overexpression. Cell Cycle (Georgetown, Tex.). PMID 30907229 DOI: 10.1080/15384101.2019.1598724 |
0.394 |
|
2019 |
Sandhu R, Wei D, Sharma M, Xu L. An N-terminal Flag-tag impairs TPP1 regulation of telomerase function. Biochemical and Biophysical Research Communications. PMID 30885434 DOI: 10.1016/J.Bbrc.2019.03.050 |
0.342 |
|
2016 |
Fan Y, Wu G, Su F, Li K, Xu L, Han X, Yan Y. Lipase oriented-immobilized on dendrimer-coated magnetic multi-walled carbon nanotubes toward catalyzing biodiesel production from waste vegetable oil Fuel. 178: 172-178. DOI: 10.1016/j.fuel.2016.03.071 |
0.318 |
|
2015 |
Nera B, Huang HS, Lai T, Xu L. Elevated levels of TRF2 induce telomeric ultrafine anaphase bridges and rapid telomere deletions. Nature Communications. 6: 10132. PMID 26640040 DOI: 10.1038/Ncomms10132 |
0.396 |
|
2015 |
Frank AK, Tran DC, Qu RW, Stohr BA, Segal DJ, Xu L. The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres. Plos Genetics. 11: e1005410. PMID 26230315 DOI: 10.1371/Journal.Pgen.1005410 |
0.37 |
|
2014 |
Tran DC, Frank AK, Xu L. Abstract 490: Investigation of telomere shortening caused by dyskeratosis congenita-associated heterozygous TIN2 mutations Cancer Research. 74: 490-490. DOI: 10.1158/1538-7445.Am2014-490 |
0.366 |
|
2013 |
Bhakta MS, Henry IM, Ousterout DG, Das KT, Lockwood SH, Meckler JF, Wallen MC, Zykovich A, Yu Y, Leo H, Xu L, Gersbach CA, Segal DJ. Highly active zinc-finger nucleases by extended modular assembly. Genome Research. 23: 530-8. PMID 23222846 DOI: 10.1101/Gr.143693.112 |
0.301 |
|
2013 |
Xu L, Li S, Stohr BA. The role of telomere biology in cancer. Annual Review of Pathology. 8: 49-78. PMID 22934675 DOI: 10.1146/Annurev-Pathol-020712-164030 |
0.379 |
|
2010 |
Stohr BA, Xu L, Blackburn EH. The terminal telomeric DNA sequence determines the mechanism of dysfunctional telomere fusion. Molecular Cell. 39: 307-14. PMID 20670897 DOI: 10.1016/J.Molcel.2010.06.020 |
0.378 |
|
2009 |
Li S, Matsuguchi T, Stohr BA, Xu L, Perry K, Ren B, Blackburn EH. Abstract IA-22: Cellular responses to telomerase perturbations Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-Ia-22 |
0.419 |
|
2009 |
Stohr BA, Xu L, Blackburn EH. Abstract B64: Telomeric DNA sequence determines the mechanism of dysfunctional telomere fusion in human cancer cells Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-B64 |
0.415 |
|
2008 |
Wang X, Kam Z, Carlton PM, Xu L, Sedat JW, Blackburn EH. Rapid telomere motions in live human cells analyzed by highly time-resolved microscopy. Epigenetics & Chromatin. 1: 4. PMID 19014413 DOI: 10.1186/1756-8935-1-4 |
0.334 |
|
2007 |
Xu L, Blackburn EH. Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres. Molecular Cell. 28: 315-27. PMID 17964269 DOI: 10.1016/J.Molcel.2007.10.005 |
0.364 |
|
2007 |
Blackburn EH, Li S, Xu L. Responses of human cancer cells to telomerase interference The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A152-B |
0.319 |
|
2004 |
Xu L, Blackburn EH. Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules. The Journal of Cell Biology. 167: 819-30. PMID 15583028 DOI: 10.1083/Jcb.200408181 |
0.392 |
|
2003 |
Kim M, Xu L, Blackburn EH. Catalytically active human telomerase mutants with allele-specific biological properties. Experimental Cell Research. 288: 277-87. PMID 12915119 DOI: 10.1016/S0014-4827(03)00217-9 |
0.353 |
|
2002 |
Comolli LR, Smirnov I, Xu L, Blackburn EH, James TL. A molecular switch underlies a human telomerase disease. Proceedings of the National Academy of Sciences of the United States of America. 99: 16998-7003. PMID 12482936 DOI: 10.1073/Pnas.262663599 |
0.318 |
|
2001 |
Tao W, Pennica D, Xu L, Kalejta RF, Levine AJ. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes & Development. 15: 1796-807. PMID 11459829 DOI: 10.1101/Gad.894301 |
0.448 |
|
2000 |
Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes & Development. 14: 585-95. PMID 10716946 |
0.36 |
|
Show low-probability matches. |